A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials

Authors:

Abstract
No abstract available
Funding Information
  • Federal Ministry of Education and Research (BMBF O1KD 1906)
  • Universitätsklinikum Würzburg

This publication has 11 references indexed in Scilit: